 |
 |
Hello Christine and all, >From: Anderson <[log in to unmask]> 6:32 PM > >Hi all, I sent an e-mail to the Sunday Star Times explaining about this >group and asked if they could e-mail me their news item so I could >forward it to the group - and guess what, it just arrived. > The university has >set up NeuronZ _ effectively the country's first major New >Zealand-owned, research-based pharmaceutical company _ to trial the >drugs and ready them for the world market. Professor Gluckman estimates The site of NeuronZ is still under construction. I also couldn't find any pressreleases by the Univ. of Auckland on this subject. Or research-reports. For further info you could try and send an email to Peter Gluckman himself....... His emailaddress is: <[log in to unmask]> Here follows some info about Peter Gluckman: Professor Peter Gluckman Executive Director of ...........?? Phone 64-9-3737-599 ext 6840 Email [log in to unmask] Why and when brain damage occurs, prevention and treatment of brain trauma, and the endocrinology and physiology of growth are Professor Gluckman's main areas of research. Professor Gluckman is also the Dean of the Auckland Medical School, and Professor of Paediatric and Perinatal Biology. Following positions as a Postgraduate research fellow, Assistant Research Paediatrician and Assistant Professor in the department of Paediatrics, University of California, San Francisco, Professor Gluckman was a visiting Professor to the department of reproductive sciences, Cornell University. He is a member of the Health research Council of New Zealand, serves on the Committee on core Health Services, and is a fellow of the Royal Society. He was formerly the Chairman of the Department of Paediatrics and director of the Animal Research Laboratories, University of Auckland. Hans.